Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoidIf approved, Dupixent would be the first and only ...

The lesions varied in size from 0.3 to 2.5 cm. in diameter and were of varying ages. Some were vesicular, some bullous and some iris-shaped. There were ulcerated lesions on the palate and buccal ...

Patients with the urticarial form of BP may never develop typical BP bullae, but continue to exhibit skin lesions typical of urticarial dermatitis (Kossard, Hamann, & Wilkinson, 2006). Histologic ...

Urticarial vasculitis (UV) presents atypical urticarial lesions and leukocytoclastic vasculitis, sometimes involving other organs. Biologics have shown potential in refractory cases unresponsive to ...

Bullous Pemphigoid Market Outlook 2025-2035: The 7 major Bullous Pemphigoid market reached a value of USD 287.1 Million in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 1,618.1 ...

Treatment should make BP more tolerable to each individual patient through the reduction of blister formation, urticarial lesions, and pruritus. Prior to the use of oral corticosteroids ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

Background: The association between psoriasis vulgaris and bullous pemphigoid (BP) remains largely unknown ... be given to the emergence of symptoms such as bullous tense blisters, urticarial plaques, ...

In this article, we explore, explain, and summarise various skin lesions that are considered mimickers of urticaria, to promote understanding of each of the conditions highlighted, improve recognition ...